SECTION I Patient Selection, 1
1 Individualized Assessment for Percutaneous or
Surgical-Based Revascularization, 5
Vasim Farooq, Rodrigo Modolo, and Patrick W. Serruys
2 Evidence-Based Interventional Practice, 43
Franz-Josef Neumann, Miroslaw Ferenc, and Kambis Mashayekhi
3 Diabetes, 65
Marco Roffi and Baris Gencer
4 Noninvasive Evaluation: Functional Testing,
Multidetector Computed Tomography, and Stress
Cardiac MRI, 81
Vikram M. Brahmanandam and Mario J. Garcia
5 Intracoronary Pressure and Flow Measure-ments, 103
Morton J. Kern, Michael J. Lim, and Katherine Yu
6 Contrast-Induced Acute Kidney Injury and the Role of Chronic Kidney Disease in Percutaneous CoronaryIntervention, 133
Roxana Mehran, Birgit Vogel, and Sabato Sorrentino
7 Radiation Safety During Cardiovascular
Procedures, 145
Beth A. Schueler, Kenneth A. Fetterly, and Stephen Balter
8 Coronary and Valvular Intervention Prior to
Noncardiac Surgery, 159
Craig R. Narins
9 Sex and Ethnicity Issues in Interventional
Cardiology, 173
Matthew R. Summers, Sahar Naderi, and Leslie Cho
SECTION II Pharmacologic Intervention, 185
10 Platelet Inhibitor Agents, 189
Matthew J. Price and Dominick J. Angiolillo
11 Anticoagulation in Percutaneous Coronary Intervention, 215 Trent Hartshorne and Derek P. Chew
12 Thrombolytic Intervention, 229
Matthews Chacko and Khalil Ibrahim
13 Other Adjunctive Drugs for Coronary Intervention: Beta-Blockers, Calcium-Channel Blockers, andAngiotensin-Converting Enzyme Inhibitors, 247 David W. Allen and Vivek Rajagopal
SECTION III Coronary Intervention, 257
14 Coronary Stenting: Practical Considerations,Equipment Selection, Tips and Caveats, 261 Elliott M. Groves and Curtiss T. Stinis
15 Coronary Stenting, 275
Tullio Palmerini and Ajay J. Kirtane
16 Bioresorbable Coronary Scaffolds, 329
Athanasios Katsikis, Rodrigo Modolo, Yuki Katagiri, Yoshinobu Onuma, and Patrick W. Serruys
17 Drug-Eluting Balloons, 343
Bruno Scheller
18 Elective Intervention for Stable Angina or Silent Ischemia, 353
Gregory W. Barsness, David E. Kandzari, and Eliano P. Navarese
19 Intervention for Non-ST-Segment Elevation Acute Coronary Syndromes, 373
C. Michael Gibson, Serge Korjian, and Yazan Daaboul
20 Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction, 391
Gjin Ndrepepa, Robert A. Byrne, and Adnan Kastrati
21 Post-Percutaneous Coronary Intervention
Hospitalization, Length of Stay, and Discharge
Planning, 439
Amit N. Vora and Sunil V. Rao
22 Interventions in Cardiogenic Shock, 451
Satya S. Shreenivas, Scott M. Lilly, and Howard C. Herrmann
23 Bifurcations and Branch Vessel Stenting, 461
Antonio Colombo and Goran Stankovic
24 Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Stenosis, 483
Jung-Min Ahn, Duk-Woo Park, and Seung-Jung Park
25 Complex and Multivessel Percutaneous CoronaryIntervention, 493
Sergio Buccheri and Davide Capodanno
26 Intervention for Coronary Chronic TotalOcclusions, 505
Ravi S. Hira and William L. Lombardi
27 Bypass Graft Intervention, 519
John S. Douglas, Jr.
28 The Thrombus-Containing Lesion, 537
On Topaz
29 Complications of Percutaneous Coronary Intervention, 565
Marvin H. Eng, Jeffrey W. Moses, and Paul S. Teirstein
30 Periprocedural Myocardial Infarction and Embolism-Protection Devices, 587
Adrian W. Messerli, Khaled M. Ziada, and Debabrata Mukherjee
31 Access Management and Closure Devices, 613
Fernando Cura and Marcelo Abud
32 Transradial Access for Cardiovascular Catheterization and Intervention, 629
鄂公網安備 42010302001612號 